SCOTT BRADLEY: Open Payments
NPI 1952761322 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$138 in 7 payments from 4 companies in 2025. Trend: 2023 $168 · 2024 $173 · 2025 $138
Food & beverage: $138
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
Products named: ZERBAXA, XIFAXAN, FASENRA, Wegovy.
Industry payments across KY — which companies pay providers there.
